Home > Publications Database > Neurochemistry of executive functions > print

001     268872
005     20240923101530.0
024 7 _ |a 10.1016/B978-0-12-820480-1.00065-6
|2 doi
037 _ _ |a DZNE-2024-00371
100 1 _ |a Lenzoni, S.
|b 0
245 _ _ |a Neurochemistry of executive functions
260 _ _ |c 2025
|b Elsevier
295 1 0 |a Encyclopedia of the Human Brain / Lenzoni, S. ; : Elsevier, 2025, ; ISBN: 9780128204818 ; doi:10.1016/B978-0-12-820480-1.00065-6
300 _ _ |a 57 - 80
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1727079207_3424
|2 PUB:(DE-HGF)
520 _ _ |a Neurochemical modulation of executive functions in the human brain is complex. While a lot still remains unknown, also concerning interactions and collaborations among neurochemical modulators as well as population-specific optimal dose-response relationships, some initial insights on the neurochemistry of executive functions exist. Fronto-striatal as well as hippocampal levels of dopamine are modulating working memory, cognitive flexibility and inhibition. Noradrenaline and acetylcholine support the regulation of attention via action on frontal as well as sensory areas. Higher prefrontal levels of serotonin are detrimental for working memory and inhibition. Higher prefrontal levels of glutamate and GABA benefit working memory and response inhibition, respectively.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef Book
700 1 _ |a Guruprasath, G.
|0 P:(DE-2719)9002076
|b 1
|u dzne
700 1 _ |a Zhunussova, A.
|b 2
700 1 _ |a Leiman, M.
|0 P:(DE-2719)9001927
|b 3
|u dzne
700 1 _ |a Ludwig, M.
|0 P:(DE-2719)9002575
|b 4
|u dzne
700 1 _ |a Penalba Sánchez, L.
|0 P:(DE-2719)9002723
|b 5
|u dzne
700 1 _ |a Hämmerer, D.
|0 P:(DE-2719)2811927
|b 6
|e Last author
|u dzne
773 _ _ |a 10.1016/B978-0-12-820480-1.00065-6
856 4 _ |u https://pub.dzne.de/record/268872/files/DZNE-2024-00371_Restricted_Encyclopedia.pdf
856 4 _ |u https://pub.dzne.de/record/268872/files/DZNE-2024-00371_Restricted_ReferenceModule.pdf
856 4 _ |u https://pub.dzne.de/record/268872/files/DZNE-2024-00371_Restricted_Encyclopedia.pdf?subformat=pdfa
|x pdfa
856 4 _ |u https://pub.dzne.de/record/268872/files/DZNE-2024-00371_Restricted_ReferenceModule.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:268872
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002076
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9001927
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9002575
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9002723
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2811927
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 0
920 1 _ |0 I:(DE-2719)1310003
|k AG Müller
|l Neuroprotection
|x 1
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1310003
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21